Cost-effectiveness and budget impact of PFO closure: Cardioform vs Amplatzer and medical therapy for secondary stroke prevention in Australia

Key Points

• The aim is to evaluate the cost-effectiveness and budget impact of PFO closure options in secondary stroke prevention.
• Comparison of Cardioform and Amplatzer devices for PFO closure
• Assessment of medical therapy costs
• Economic evaluation using budget impact analysis
• Cardioform demonstrated higher cost-effectiveness compared to Amplatzer
• Support for the adoption of Cardioform in clinical practice for stroke prevention